There are 2137 resources available
1105P - Estimating long-term survivorship in patients with advanced melanoma treated with immune-checkpoint inhibitors: Analyses from the phase III CheckMate 067 trial
Presenter: Peter Mohr
Session: E-Poster Display
Resources:
Abstract
1106P - International experience of ipilimumab and nivolumab in patients with advanced melanoma
Presenter: Patricio Serra-Bellver
Session: E-Poster Display
Resources:
Abstract
1107P - Clinical outcomes to checkpoint inhibitors in NRAS mutated metastatic melanoma (MM) compared with wild type BRAF/NRAS: An Italian Melanoma Intergroup (IMI) study
Presenter: Michele Guida
Session: E-Poster Display
Resources:
Abstract
1108P - Real world (RW) sequencing outcomes with immunotherapy and targeted therapy (TT) in BRAF+ metastatic melanoma (The NOBLE study series)
Presenter: Allison Warner
Session: E-Poster Display
Resources:
Abstract
1109P - Chinese subgroup results from an open-label, phase IIa study of dabrafenib plus trametinib in Asian patients with advanced BRAF V600-mutant melanoma (NCT02083354)
Presenter: Lili Mao
Session: E-Poster Display
Resources:
Abstract
1110P - Efficacy of salvage therapies after failure of anti-PD-1 monotherapy for advanced melanoma in an Asian population: A multi-institutional historical cohort study
Presenter: Yukiko Teramoto
Session: E-Poster Display
Resources:
Abstract
1111P - Suboptimal real-world (RW) outcomes for BRAF+ metastatic melanoma (MM) patients in 2L therapy (The NOBLE study series)
Presenter: Ahmad Tarhini
Session: E-Poster Display
Resources:
Abstract
1112P - Intralesional therapy with talimogene laherparepvec for stage IIIB-IVM1a melanoma is able to achieve a high rate of complete and durable responses and is associated with tumour load
Presenter: Emma Stahlie
Session: E-Poster Display
Resources:
Abstract
1113P - Mortality prediction in real world advanced melanoma patients treated by anti-PD1 within MelBase, a French multicentric prospective cohort
Presenter: Bastien Oriano
Session: E-Poster Display
Resources:
Abstract
1114P - A real-world study of vemurafenib plus anti-PD-1 antibody in Chinese patients with advanced BRAF V600-mutant melanoma
Presenter: Xizhi Wen
Session: E-Poster Display
Resources:
Abstract